Annual SHOT Report 2019: ADU highlights webinar
The SHOT team will host its first webinar of 2021 on 28 January, 1400–1500 GMT, and cover the Avoidable, Delayed or Under/Overtransfusion (ADU) chapter of the Annual SHOT Report 2019. Click on this story for the link to register.
This one-hour free-to-access online event will include:
- A 40-minute presentation by the SHOT Team and the SHOT ADU Working Expert Dr Paula Bolton-Maggs, covering the key highlights from the ADU chapter of the 2019 Annual SHOT Report
- A 20-minute interactive Q&A session
- An excellent opportunity for CPD through reflective practice.
This webinar will be relevant to all healthcare professionals involved in transfusion – laboratory staff, clinicians, transfusion practitioners and haemovigilance specialists, as well as quality assurance professionals.
Click here to register.
The Zoom link to the live event is contained in the registration email.
You can also contact SHOT directly to register by email ([email protected]).
The event will commence promptly, so please join at least five minutes prior to the start.
DiaSorin is an Italian multinational Group and a global leader in the market for in vitro diagnostics. DiaSorin is listed on the MTA (automated stock market) in the FTSE Italia Mid Cap Index, organized and managed by Borsa Italiana S.p.A
For over 40 years the Group has been developing, producing and commercializing diagnostic tests for a wide...